FTC targets spammers
This article was originally published in The Tan Sheet
A U.S. district court in Illinois ordered a halt to spam e-mails and bogus claims for Kaycon's hoodia weight-loss supplements and human growth hormone anti-aging products after FTC filed a complaint against the firm. Kaycon falsely claimed its hoodia products would cause rapid and substantial weight loss, "including as much as 40 pounds in a month" and its HGH products would "turn back or reverse the aging process," among other claims, FTC states. The federal court ordered an ex parte temporary restraining order and asset freeze of the firm, and will decide after an Aug. 27 hearing whether to extend the asset freeze until the FTC's case is resolved. The FTC ultimately seeks to permanently bar the firm from further violations and it forfeit its "ill-gotten gains"...
You may also be interested in...
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Health technology assessment body NICE has now recommended that selective internal radiation therapy can be used on England’s National Health Service for treating advanced liver cancer.
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.